Revocation of European patent for neural progenitors highlights patent challenges for inventions relating to human embryonic stem cells

Author： Rigby Barbara  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.23, Iss.11, 2013-11, pp. : 1395-1398

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Updates on Therapeutics in Clinical Trials for Spinal Cord Injuries: Key Translational Applications of Human Embryonic Stem Cells-Derived Neural Progenitors

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 10, 2016-12 ,pp. : 1266-1278

Bentham Science Publishers

Access to resources Recommend Favorite

Patent Highlights

By Mucke Hermann AM  

Pharmaceutical Patent Analyst, Vol. 2, Iss. 4, 2013-07 ,pp. : 459-465

Future Science

Access to resources Recommend Favorite

Patent Highlights

By Mucke Hermann AM  

Pharmaceutical Patent Analyst, Vol. 2, Iss. 5, 2013-09 ,pp. : 603-610

Future Science

Access to resources Recommend Favorite

Patent Highlights

By Mucke Hermann AM  

Pharmaceutical Patent Analyst, Vol. 2, Iss. 2, 2013-03 ,pp. : 187-194

Future Science

Access to resources Recommend Favorite

Patent Highlights

By Mucke Hermann AM  

Pharmaceutical Patent Analyst, Vol. 2, Iss. 3, 2013-05 ,pp. : 309-316

Future Science

Access to resources Recommend Favorite